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Abstract How can a realistic ethical imagination about the future of a technology
take shape? This article contains a reflection which is based on the experiences of an
embedded ethicist in the context of biophysical research conducive to the devel-
opment of photoacoustic mammography, which is intended for the non-invasive
detection of breast cancer. Imagination in this context already informs the activities
of the biophysical researchers, but its role is limited: biophysical future scenarios
concentrate on the technological advances that photoacoustics could bring about. In
this article it is argued that it is advisable to also consider the medical practice and
the ways in which this practice is likely to change as an effect of the introduction of
photoacoustic mammography into it. On the basis of this more encompassing
imaginative endeavor it is possible to get a clearer idea about how new technologies
are able to contribute to human well being, which is informative for the setting of
research-goals/priorities and a responsible implementation of new technologies into
the world.
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In the Netherlands STW—the most important Dutch public financer of technology
research—has started a pilot project of four embedded ethical researches. These are
the so called ethical parallel researches, that are carried out parallel to the research
of technological researchers. The idea behind this type of research is that ethicists
should not pass judgment on new technologies after they are already researched and
developed, but during the research process, thus allowing technology researchers to
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actually do something with the criticism and suggestions that they get from ethicists.
In this way ethicists who are engaged in the technology research process are thought
to be able to co-shape new technologies in ethically sound ways.
It is not yet clear whether it is realistic to expect technologies to change as an
effect of the simple engagement of one ethicist in the research phase. There are a lot
of obstacles to such cooperative co-shaping; for example, the research phase in
which the ethicist is engaged is but one of the episodes in the generation of a new
technology, but a lot has been decided before the ethicist came on the scene and a
lot will be decided after the ethicist left. Before the research phase the research plan
has been written and selected for funding and the researchers accepted the
responsibility to realize the goals of that plan, which makes it hard to change those
goals; and after the research phase a producer will invest in the further research and
development of the technology into a useable product. If ethical reflections that play
a role during the research phase are not sustained in these other phases, it is the
question whether embedded ethicists exercise any influence at all over the resulting
technology.
Another obstacle is that it is quite new to engage an ethicist in the research phase,
and this requires changes in the practice of researchers as well as in ethics.
Researchers expect ethicists to adopt the role of an outsider-judge who utters
judgments with a negative heuristic—that is, which express what not to do, or what
harms to avoid—and therefore it is unsurprising that they look at the ethicist with
suspicion, for they are afraid she will tell them to stop doing this research. On the
other hand, co-shaping a technology for ethicists demands the adoption of a role that
is quite unfamiliar to them; namely, the role of an ‘insider’—a participant, or rather
‘parallel participant’—in the research practice. While some authors—such as
Alasdair MacIntyre and Michael Walzer [1–3]—have already defended the view
that (ethical) critics should adopt such an insider-position in theoretical accounts,
and that they should try to contribute to the improvement of such practices. But they
have not reflected on question what form this should take in the specific practice of
a technology research.
This article reflects about how ethicists who are embedded in a context of
technology research could carry out their task. In order to come to grips with the
technology that technological researchers are striving to realize, and that an
embedded ethicist is expected to co-shape, it seems wise to think about the question
how one could realistically imagine the future of a technology. Such an imagination
could help to form an ethical language with a more positive heuristic, which
expresses advises about what to do that help to form a future technology in a way
that contributes to human well being.
The background of this article is my own work as an embedded ethicist in the
context of research at the Institute for Biomedical Technology at the University of
Twente (the Netherlands) into a new technology called ‘photoacoustic mammog-
raphy’, which is a hybrid technique which uses sound and light for the non-invasive
detection of breast tumors. How could an ethicist think about the future of this
technology? In this article I would like to imagine the future of photoacoustic
mammography, and at the same time do a proposal about how such anticipation can
be structured in the context of an embedded ethical research. Such an imagination
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should not be a wild invention; it should be—with a term by Lorraine Code—an
‘educated imagination’ [4, p. 206]. Just like researchers creatively invent new
research-topics in an ‘educated’ way, building forth on previous knowledge and
research methods, ethical imagination should also be the product of a controlled
reflection: it should avoid the pitfalls of an ethic that either leaves too little room for
imaginations about the future, or departs in highly speculative hypotheses about the
future of technologies that have little chance of ever becoming reality.1
In this article I propose to start this controlled imaginative endeavor with the
future scenarios that technology researchers themselves aim to realize. I call their
future goals the ‘technical scenarios’. But I will also show that these technical
scenarios have limitations; they are primarily concerned with the technological
change that a new technology may produce. It seems to me that an ethicist can assist
in enlarging the imaginative scope that directs technology research to also include
the ways in which a new technology is able to change the medical practice in which
it will be used, in better and in worse ways for human well being. This enlarged
imaginative endeavor provides material that helps to reflect more responsibly about
what research goals to choose, or how to set priorities, and about what to pay
attention to during the phase of implementation in the future.
Step 1: Learning About the Technical Future Scenarios
Photoacoustic mammography builds forth on Near Infrared (NIR) optical imaging
technologies that are being researched at different institutes, among others in the
US, Great Britain and the Netherlands for their capacity to detect cancer [11–15].
NIR optical imaging images the excessive growth of bloodvessels around tumors
the breast, a process termed ‘angiogenesis’ [16]. NIR optical imaging points out that
it is possible to image these vessels in a suspicious area in the body when one points
a light beam of near-infrared laser light at it and notes the degree of light-absorption.
Higher absorption is taken as a signature of a vascularized tumor [13, 14]. The
optical imaging technique is a promising technique because it avoids ionizing
radiation, it is relatively inexpensive, and it does not require severe breast
compression.
However, the optical imaging technique produces images with poor resolution
because the blood vessels it pictures are located in the body and surrounded by
tissue which strongly scatters the light. The poor resolution of the image makes it
hard to distinguish clearly between the diseased and the healthy part of the body.
The photoacoustic technique—also referred to as optoacoustic—is an attempt to
1 A lot has been written about the ways in which imagination of the future can benefit ethical reflection
about technology. For e.g. [5–10] But not all ethicists are convinced that imagination should have a role
in ethical reflection on technology. While some ethicists think the public debate about technology suffers
from a lack of imagination and ethicists should make it more creative [7–9], others argue that ethicists
should refrain from imaginative endeavors because they start to discuss cases that are far from realistic
[10]. According to Alfred Nordmann ethicists would do better to focus on ‘visions that underwrite
ongoing research’ which include presuppositions in scientific research about, for example, the mechanical
nature of human bodies, an idealistic view of autonomy or a consumer interpretation of choice [10,
pp. 45–46].
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avoid these problems by means of the use of a combination of ultrasound and
laserlight, which is invented as a way to distinguish between the absorbed photons
and the scattered photons, and concentrates on the absorbed ones for the signal [15].
Several research groups have investigated ways to realize a photoacoustic
technology [17, 18]. Researchers of the Biophysical Engineering Group in Twente
invented an original way to use sound and light for breast cancer detection, and a
first test suggests that it has promising results [19]. The Twente method is to use a
pulsed light beam that produces a temporal temperature raise and a short expansion
at locations where the light is absorbed by blood, followed by a temperature drop
and a contraction [20, 21]. The thermal expansion resulting from the temperature
rise, produces a sound wave that can be pictured with an ultrasound detector.
What are the advantages that photoacoustic mammography could bring about in
the future? I did numerous extensive interviews with five researchers; one
postdoctoral researcher who carried out the research, two members of the
permanent scientific staff, a full professor and an assistant professor, and a
radiologist and an oncologist who took part in the testing on patients. In those talks I
found out that several future scenarios figure in the minds of the researchers, which I
articulated, distinguished, ordered and discussed with them. Each scenario explores
different possible future capacities, to which the researchers refer with the terms
‘specific’ and ‘sensitive’. Sensitive technologies have screening potential; they are
able to detect a lump, but they have limited capacity to distinguish between a
malignant and a benign lump.2 Specific technologies, by contrast, are able to
determine the diagnosis; they specify which lumps in the breast are harmless cysts
and which ones are cancer. In the present medical practice there is a distinction
between the technologies that are used for screening and the technologies that are
used for diagnosis. Most often ultrasound and X-ray mammograms are made to
screen whether there is a lump there; a biopsy determines whether the lump is
cancer or not. Generally X-ray mammography is thought to set the ‘golden
standard’ for screening and the biopsy for diagnosis, which means that the
capacities of all newly invented instruments for screening and diagnosis are
evaluated respectively in comparison to the performance of X-ray mammography
and biopsies.
In the future scenarios of photoacoustic mammography, the researchers imagine
their technology to offer an alternative to the technologies that are accepted at
present as the ‘golden standard’. While they are modest about what they are able to
deliver now, and they continually affirm that a lot further research is needed before
any of the capacities of the imaginary future photoacoustic mammography can be
realized, the following scenarios do figure in their thoughts about what their
research-activities are eventually aiming at. In the first future scenario, they ascribe
to photoacoustic mammography primarily a diagnostic role. In this scenario
photoacoustic mammography would replace part of the biopsies. It would thus be
primarily a diagnostic tool, a specific technology, which would be used after a lump
has been detected with an X-ray mammogram.
2 For example, a sharp edge of the lump in the breast, as opposed to a diffuse one, is in most cases—but
not all—a sign that it is a benign anomaly.
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The second scenario further explores the potential of photoacoustics as a specific
technology. The aim of this research is to find out whether photoacoustics is able to
offer information about the amount of oxygen in the blood surrounding a tumor,
because blood with a lot of oxygen absorbs less light than blood with little oxygen,
which has a darker color. Oxygenation of the blood is thought to be indicative of the
speed with which the tumor is growing: little oxygen is expected to mean that the
tumor grows fast, for it needs oxygen to grow. If photoacoustics is able to offer
information about oxygenation, the technologists think it may be able to offer
information that is important for the physician’s choice for adequate treatment.
However, this research is not the primary interest of the radiologist and the
oncologist who are engaged in the testing of photoacoustic mammography on
patients, because there are no treatments available at present that aim specifically at
fast or slow growing tumors.
The third and the fourth scenario focus also on the sensitive potential of the
technology. In the third scenario photoacoustic mammography would not only be
used for diagnosis, but also for screening. It would thus have specific as well as
sensitive capacities, and could eventually replace the biopsies and the X-ray
mammography. This is the scenario that interests the oncologist and the radiologist
most. In fact they talk about this technology as if this is the only future that it is
intended to bring about. The scientific staff agrees that this scenario is important and
valuable, and that it is possible that this will become reality. But some are a little bit
more skeptical than others whether it is feasible. Whether photoacoustics will
become successful as a screening technology depends on whether this technology
will be able to detect cancer in an earlier phase than X-ray. That means that further
research should establish whether or not the formation of extra vessels which can be
detected with photoacoustics can be seen before a lump is formed that can be
detected with X-ray.
The fourth scenario comes forwards in the expression of the researchers’ interest
to investigate the possibilities of this technology to diagnose cancer in glandular
breasts. Glandular breasts are hard to picture with X-ray mammography; a lot of
pictures have to be taken in order to get a clear view of what is inside, which is
harmful with X-ray’s ionizing radiation. And even when the breast is pictured from
all sides, X-ray mammograms miss up to 25% of the breast cancer in glandular
breasts [22]. This is known to be a problem especially for younger women, for it is
known that breasts become less glandular with age. While it is expected that
photoacoustic mammography will also have to take a lot of pictures in order to
traverse breasts with a lot of glands, it is thought to be able to offer an accurate
image and it uses harmless radiation. This capacity of the technology is not
currently being researched, but it is a very important research-topic that the
researchers want to explore in the near future.
An overview of these scenarios show that the researcher’s imagination about the
future capacities of photoacoustics focuses primarily on technological advances: the
researchers look at the technologies that are used in the present medical practice and
look how photoacoustics is able to transcend the limitations of these technologies.
In comparison to a biopsy, a noninvasive photoacoustic image offers a painless way
to diagnose. And it may produce information on the speed of growth that is
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unavailable at present. In comparison to X-ray mammography, a photoacoustic
mammogram uses harmless radiation, the breast does not need to be pressed that
hard to get the picture (which reduces pain) and it may be able to produce better
results on young women. In comparison to NIR optical imaging, photoacoustics
offers an image with a better resolution.
In comparison to all these technologies, photoacoustic mammography is thought
to be able to offer an improvement. What the researchers do not take into account in
their future imagination, is how the introduction of photoacoustics in the medical
context may change that context, and accordingly the lives of people. However,
when they exclude the medical practice in their reflections, they do not expand their
imagination in ways that are ethically informative. That is what I would like to show
in the next two paragraphs.
Step 2: Learning About the Practice to Which the Technology Contributes
The medical practice for which photoacoustic mammography is intended is the
practice of breast cancer screening and diagnosis. This can have many forms. It
could for example mean that women who feel an anomaly in one of their breasts are
sent by the general practitioner to a hospital where they would have a photoacoustic
mammogram taken, in stead of an X-ray mammogram or an ultrasound image,
sometimes with a biopsy, which is the practice at present. But the most important
reason why this technology is economically interesting is that it could be used in the
preventive public screening service, which has been gradually implemented in many
European countries and in North America during the past decades. This preventive
screening service is most commonly offered annually or bi-annually to a population
of women past the menopause, between 50 and 70 or 75 years of age. Especially the
use in this screening practice needs attention, for since 2000 there has been a fierce
discussion over the utility of these preventive screening services with X-ray
mammography which remains inconclusive until this day. The disagreement
concentrates on two issues, namely (1) that it remains unclear whether screening
with X-ray mammography reduces breast cancer death rates (and with what number
they are reduced) and (2) that the unavailability of knowledge about the reduction of
the death rates makes it impossible to determine whether the benefits of screenings
outweigh the costs in terms of physical harm due to the ionizing radiation (the
ionizing radiation of X-ray is expected to have a carcinogenic potential) or to
unnecessary treatments (following on false positive results), inconvenience,
emotional stress and physical pain because of the compression of the breast.
What are the reasons to doubt whether screenings are beneficial? During the
1980s and 1990s many studies have been done in North America and in different
European countries that pointed out that frequent screenings—like, say, annually or
biannually—help to reduce breast cancer mortality. But not all studies produced this
favorable result. One famous large scale Canadian study did not find a reduction of
breast cancer death rates as a result of the introduction of annual screenings with
X-ray mammography [23–26]. And a smaller study in the Swedish county Malmo¨
also did not show a benefit of screenings. Both studies, especially the Canadian one,
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were severely criticized. However, in 2000, two Danish researchers, Peter Gotzsche
and Ole Olsen, working at the well respected Nordic Cochrane Center in
Copenhagen published a critical survey in the Lancet of all scientific research
about the relation between screenings with X-ray and the reduction of breast cancer
death rates, and they argued that all but two of the trials were flawed in design to the
effect that the results were unreliable [27]. In their opinion the Canadian study and
the Malmo¨-study were most reliable.
The Danish researchers came to this conclusion on the basis of a critical survey
of the way in which eight extensive trials were carried out; beside the Canadian and
the Malmo¨ study they judged all of them to be biased. They remarked for example
that a lot of these trials excluded women who had been diagnosed with breast cancer
previous to the trial, which influences the final results; for women who have had
breast cancer in the past are more likely to eventually die of breast cancer than other
women, and when they are excluded the number of deaths in the screened
population is likely to drop. Next to that, they criticized some trials because they
worked with unbalanced test and control groups. In a reliable trial the test group and
control group are exactly the same. However, in trials that were carried out in New
York and Sweden the number of women in each group was not the same, and even
remained unclear.3 When the number of people in the screened study group is
smaller than in the control group (which was the case in New York) this introduces a
bias in the study in favor of the screening group. Also, many studies did not verify
whether the study group and the control group consisted of similar populations; in
the New York study there were imbalances in both groups about the medical history
(previous lumps in the breast), age (pre or post menopausal) and education level. In
the Edinburgh study 26% of the control group was in the highest socioeconomic
stratum, compared with 53% in the screening group. In Stockholm and Go¨tenborg
the study women were on average younger than the women in the control group.
Additionally the Swedish trials contained another mystery: while for every 1,000
women screened biannually for 12 years, one breast cancer death is avoided, the
total number of deaths increased by six [28].
All of the trials that Gotzsche and Olsen condemned biased pointed out that
screenings with X-ray mammography help to reduce breast cancer mortality. The
only two trials they judged to be unbiased pointed out that screening for breast
cancer with mammography had no effect on breast cancer mortality. From these
findings the researchers ‘‘(…) conclude that screening for breast cancer with
mammography is unjustified.’’ [27, p. 133]
Next to the opinion that breast cancer screenings do not reduce the amount of
breast cancer deaths, Gotzsche and Olsen also argue that screenings inflict harm,
because they lead to over diagnosis and over treatment. Both of the unbiased trials
show that surgery and radiotherapy is significantly more common in groups of
women who are screened than in women who are not screened for breast cancer.
3 In the New York trial the number varies between 31,092 and 30,000 in the study group, and between
30,565 and 30,765 in the control group [27, p. 129]. In the Stockholm trial the number of controls is
20,000 in an early report and 19,943 in the final report. In the final report of the Swedish trials the number
of women in the screened group fell from 40,318 to 38,525 and increased in the control group from
19,943 to 20,651 [27, p. 130].
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This seems natural, for when there is screening, more tumors are found, so more
treatment is needed. However, the Danes think it is also possible that the number of
treatments will augment because of ‘‘(…) false-positive findings, cell changes that
may never develop into cancer, and cancers that will develop so slowly that the
woman dies of other causes before the cancer becomes apparent.’’ [27, p. 133]4
This observation by Olsen and Gotzsche was the start sign for a fierce debate.
Critics of this Danish view noted that the flaws that Olsen and Gotzsche identified
were not severe enough to discount the body of evidence that supported the view
that screenings reduced the death cancer death rate [29, 30]. Even if the trials were
not securely carried out, and they do not offer exact information as to how many
breast cancer deaths are prevented with screening, they could not be completely
discarded either. The Danes, however, continued to reassess their findings [28, 31].
For example, in an article in 2001 in which they report also new evidence which
shows that screening brings about an increase in the number of surgeries,
chemotherapy and radiotherapy. In this article this is reason for them to suspect that
screening will not reduce, but increase overall mortality because of cardiovascular
effects [28].
In the years to follow the debate flared up each time a new trial was presented,
but the disagreeing parties never came to an agreement.5 Eventually the parties just
became tired of the debate and stopped repeating their standpoints [22]. The only
randomized study that appeared and which is sensitive to the criticism, while also
showing that screening has a significant but modest effect on mortality from breast
cancer, is a Swedisch study by Nystro¨m and his colleagues from 2002. This study is
currently cited as the only trustworthy one that shows a positive effect of breast
cancer screenings with X-ray mammography on breast cancer death rates. The
Nystro¨m-study shows that reduction in breast cancer mortality is 27% among 55–64
year old women, and deaths were reduced 14% among those forty-five to fifty-four
who were screened [35]. But until now this has been the only reliable study that
shows such a favorable effect. The Canadian study and the one carried out in Malmo¨
do not show it.
4 The Canadian trial especially fueled this argument against screening, for it pointed out that the number
of benign findings in biopsy samples was two to four times higher in the screened groups than in the
control groups.
5 For example, at the presentation of another Swedish research, which used the data of the regional
oncology Centers in Uppsala and Linoping in Sweden to compare deaths from breast cancer in the twenty
years before screening was introduced (1958–1977) with those from breast cancer diagnosed in the
twenty years after the introduction of the screening (1978–1997). The findings show that among women
aged forty to sixty-nine who were screened, there was lower breast cancer mortality to those diagnosed
prescreening. In the twenty to thirty nine age group, there was no significant difference in breast cancer
mortality in 1978 to 1997, compared with 1958 to 1977 [32]. But Peter Gotzsche wrote in a short response
that this historical approach is also unreliable [33]. He argues that screening predominantly identifies
slow-growing tumors, so women with breast cancer diagnosed during screening generally have a better
prognosis, than the women diagnosed pre-screening for these diagnoses also included the quick growing
tumors, which are more dangerous. According to Gotzsche a randomized study is needed to determine the
effect of screening on death rates, but of course he criticized already all randomized studies because of the
unbalanced test and control groups. This criticism also affects another research carried out in the
Netherlands [34].
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Reading about the inconclusive controversy over the benefits of beast cancer
screenings with X-ray mammography, raises questions that are relevant to
researchers who are in the process of researching a new technology for that
context. A new technology such as photoacoustics could improve the benefits of a
screening practice, in the sense that some of the future scenarios that the technology
researchers sketch—if they turn out to be realizable—could succeeds to reduce
breast cancer death rates as well as the false positive and false negative diagnoses,
which would of course help to promote human well being. If it would do that,
important arguments against screening which are put forwards in this debate would
loose their force.
However, at present the debate over screening with X-ray mammography is
generally ignored in the context of research into photoacoustics. While some of the
technological researchers who work on photoacoustics took notice of the debate, it
did not affect their work. The reason for that is that they consider it their task to
study the drawbacks of the technologies being used and try to transcend those in a
new technology; they do not think it is their responsibility to think about how to
contribute to the improvement of the practice of breast cancer screening so that it
helps to improve human well being.
In my opinion this is a missed opportunity. When we reconsider the technological
future scenarios that I distinguished in section one and engage in an additional
imaginative endeavor to establish whether or not each of these scenarios could
contribute to the improvement of the results of the screening practice, we come to
another view of what scenarios are worth to try to realize, and which ones present
less valuable goals to pursue. That is what I want to show in the next section.
Step 3: Ethical Future Scenarios of Photoacoustic Mammography
The most important arguments against screening with X-ray mammography that are
put forwards in the debate are (1) that screening with X-ray mammography does not
reduce breast cancer death rates, or reduces them only minimally and (2) that
screenings actually harm women; they cause inconvenience, emotional stress and
physical pain to all women but especially to women who receive false positive
results and who are offered treatment that they don’t need. And next to that, the
ionizing radiation of X-ray is expected to have a carcinogenic potential.
What effects would the realization of the technological future scenarios that the
researchers sketch have on these drawbacks of the screening practice? According to
the first technical scenario photoacoustic mammography would succeed to replace
part of the biopsies. That would mean that women with a suspect lump in their
breast do not always have to have a painful puncture taken and they can have their
results very quickly by means of a non-invasive photoacoustic mammography. In
this scenario photoacoustic mammography helps to reduce the physical pain and
emotional stress that a biopsy causes. So, photoacoustics in this scenario takes away
some of the harm that the current diagnostic practice inflicts, but it does not make it
more successful in reaching its goal of reducing the amount of breast cancer deaths.
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The second technological scenario suggests that photoacoustics may in the future
be able to point out the oxygenation of the blood around a tumor, and that
oxygenation could be informative of the speed with which a tumor grows or spreads.
Would this improve the present practice of breast cancer screening and diagnosis?
The physician in the research team reports that there is no special treatment for fast
and slow-growing cancers available at this moment, so this scenario cannot be
expected to lead to a reduction of death rates in any near future.
If the third technological scenario would be realized in which photoacoustic
mammography would prove capable of sensitive screening, the technology would
could contain more favorable promises for human well being. Next to the
expectation that the process of breast cancer screening and diagnosis becomes less
burdensome if photoacoustics were used for diagnosis as well as screening—it
would shorten the sequence of medical checks and the process would involve less
physical pain—using photoacoustics for screening could also help to reduce death
rates for it does not use harmful radiation that has the potential to produce cancer,
such as X-ray mammography is thought to do. Besides, if photoacoustic
mammograms turn out to be able to detect cancer earlier than X-ray mammograms,
than it could be possible that screening with photoacoustics helps to reduce the
amount of breast cancer deaths in the future.
What about the scenario in which photoacoustic mammography turns out to be
able to detect breast cancer in glandular breasts? While this could of course be very
beneficial for the well being of young women, who are known to have more glands
in their breasts [36], especially to those with a genetic predisposition to get breast
cancer. But a probable side-effect could be that it will become very difficult to avoid
an extensive enlargement of the present population to be screened. Until now,
women younger than 50 years of age have generally been excluded from the
screened population in countries that have a public screening service, such as the
Netherlands or Sweden. For women beneath 35 years of age the reason for this
exclusion is biological: breast cancer is rare among women of that age group. But
women between 40 and 50 years of age have a higher chance of getting cancer. This
group is generally excluded from the screened population for a technological
reason: X-ray mammograms miss up to 25% of breast cancer in women before their
menopause (as opposed to 10% for women in their fifties and older) [22].
If photoacoustic mammography turns out to be able to make mammograms of
pre-menopausal glandular breasts, this is a reason to extend the age-group to be
screened. When there is no longer a technological reason to exclude women in their
forties, fairness requires to offer screenings to them too. Interestingly, this means
that if the possibility to use photoacoustic mammography is realized, it not only
opens the possibility to choose to include younger women; it also makes it difficult
to avoid including them: it becomes unjust not to do it.6
What would the effect of this scenario be on human well being? Of course, if
photoacoustic mammography is able to detect cancer in an early phase in young
6 Furthermore, research of the kind of cancers that women in their forties develop may point out that this
group ought to be screened more often—for example, annually in stead of biannually which is currently
the standard in the Netherlands—because the cancers they develop grow faster. A more frequent
screening is of course also more expensive.
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women’s breasts, this causes an improvement of the well being of young women
who develop cancer. But this positive effect has a negative counterpart. An
enlargement of the present breast cancer screening practice also means that a larger
population of mostly healthy women is subjected to bi-annual or annual screenings.
This means an augmentation of the costs of this service and this money can no
longer be spent on other important goals, such as reducing the waiting list for
surgery or care for the terminally ill.
Next to that, it also seems important to note that an enlargement of the present
screening practice may also bring about cultural changes, for example in the
experience of health and disease; being healthy might loose its sorrowless nature
when one is expected to regularly subject oneself to medical checks. But people
may also start to attach much more value to health as a value in their lives, once
they’re expected to engage in more and more activities to preserve it and therewith
loose other important sources of value out of scope. Lastly the extend to which one
is held responsible for one’s own health (and blamable for loosing it) may change
radically, and consequently the norms may change too about who deserves priority
on the waiting list for surgery, or who deserves to be insured.7
Conclusion
While the biophysicists who research photoacoustic mammography have a very
lively imagination, it focuses narrowly on technological devices and how they can
be improved. Their imaginative endeavor does not include the context, the practice,
in which the technology will be used. I think an embedded ethicist who is able to
broaden that imagination to include also the practice for which the technology is
intended, may help to enhance the creativity of researchers and in this way
contribute to choices that are well argued for about what research-goals to pursue or
to give priority.
At present, the research-goals are primarily determined by the topics that the
researchers find most scientifically challenging, as well as the ones they succeed to
get funding for. But next to scientific interest, all researchers also claim that they
find it important to contribute to human well being. An imagination that includes
information on the medical practice for which their technology is intended, and
seeks to determine which technological scenarios will enable that practice to
promote human well being, can help to make well informed research choices. In the
case of photoacoustic mammography this imaginative endeavor has produced the
insight that the scenario in which photoacoustics is used for screening is more
helpful if one wants to remove the drawbacks of the current practice of breast cancer
screening and diagnosis, and help it to become more effective in achieving the goal
of a reduction in the breast cancer death. That would mean that an ethicist who
wants to promote human well being would advise the researchers to give priority to
7 These and similar issues are well described in the extensive literature on ethical aspects of
medicalization. Marcel Verweij gave a helpful overview in his article ‘Medicalization as a moral problem
for preventive medicine’ [37].
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research that determines whether photoacoustics is a sensitive technology which can
be used for screening, and not try to develop its specific capacities for diagnosis
further. At this moment however, the primary focus of the researchers is on the
specificity of the instrument, not on its sensitivity.
In addition, the broader ethical imagination gives reason to be cautious in a later
phase, when the technology will be implemented in medical practice. As was
discussed above, the screening practice may enlarge, if the technology turns out to
be able to screen cancer in young women’s breasts. This is a situation that needs to
be anticipated. Careful reflection is needed about whether or not this is desirable,
and about how to keep the practice small, if there are other more important medical
services that need the budget.
A broadening of the imaginative endeavor thus helps to set research-goals and
priorities, and to direct research activities as well as the final implementation of a
technology. But it also produces a change in the research practice as a whole. Until
now the biophysical researchers understood their responsibility primarily in
technological terms; they see it as their task to transcend the limits of the present
technologies with new technologies. However, taking the recommendations of an
ethicist seriously, who engages in a broader imaginary journey that includes also the
medical practice, would imply a reorientation in the reflections about one’s own
responsibility as a technology researcher. Including an ethicist in such a context, and
taking the suggestions seriously that he or she offers, could mean that technology
researchers are motivated not only to think about technological innovations they
may be able to deliver, but also to take into consideration the effect of those
innovations on human (social) life.
Changing the research practice in this way also offers an important subject for
discussion with public institutions that offer funding to technological research-
proposals. If public funding institutions are interested in the impact of new
technologies on human lives, they should make more room for such an evaluation
in their assessment of research projects. In that way they could sustain this type of
reflection, and enforce its influence in the research practice. At this moment,
public institutions in the Netherlands—such as STW or Senter Novem—but also
in the US—NSF—express an interest in the ‘societal relevance’ or the ‘broader
impacts’ of technology research, but it remains rather vague what these terms
mean. In my opinion it could mean that the impact of new technologies on human
life and practices is anticipated already in an early phase of the research. A
broader ethical imagination, as is offered in this article, could help to come to
such an anticipation. If funding institutions would enforce this kind of ethical
imagination about technology, they could contribute to the development of a
reflective research practice that takes seriously the way in which technology
changes human life.
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